| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1084252259 |
| P356 | DOI | 10.1186/S13075-017-1238-8 |
| P932 | PMC publication ID | 5372299 |
| P698 | PubMed publication ID | 28356164 |
| P2093 | author name string | Xiaosong Wang | |
| Jing Sun | |||
| Yi Yuan | |||
| Genhong Cheng | |||
| Lili Song | |||
| Mingyue Yang | |||
| Zhenyu Jiang | |||
| Xue Diao | |||
| Kuo Wang | |||
| P2860 | cites work | A Toll-like receptor recognizes bacterial DNA | Q24290668 |
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Lupus nephritis: the evolving role of novel therapeutics | Q26998390 | ||
| Targeting the Transforming Growth Factor-β Signaling in Cancer Therapy | Q27021750 | ||
| Analyzing real-time PCR data by the comparative C(T) method | Q28131831 | ||
| Three novel mammalian toll-like receptors: gene structure, expression, and evolution | Q28140533 | ||
| Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542 | Q28204648 | ||
| Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. | Q33731760 | ||
| Toll-like receptor 9 enhances nephritogenic immunity and glomerular leukocyte recruitment, exacerbating experimental crescentic glomerulonephritis. | Q34254371 | ||
| TLR agonists regulate PDGF-B production and cell proliferation through TGF-beta/type I IFN crosstalk | Q34324873 | ||
| Mesangial cells in the pathogenesis of progressive glomerular disease in animal models | Q35541989 | ||
| Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. | Q35773580 | ||
| TNF-α and TGF-β counter-regulate PD-L1 expression on monocytes in systemic lupus erythematosus | Q35795451 | ||
| American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis | Q36221407 | ||
| SLE: translating lessons from model systems to human disease | Q36254076 | ||
| CCN4 induces IL-6 production through αvβ5 receptor, PI3K, Akt, and NF-κB singling pathway in human synovial fibroblasts | Q36903170 | ||
| miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1 | Q36977367 | ||
| Toll-like receptors in systemic lupus erythematosus; prospects for therapeutic intervention. | Q37250282 | ||
| Transforming growth factor beta as a therapeutic target in systemic sclerosis | Q37428739 | ||
| Expression of toll-like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus | Q37639733 | ||
| Updates on the treatment of lupus nephritis | Q37807212 | ||
| TLR7 and TLR9 in SLE: when sensing self goes wrong | Q37995556 | ||
| Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides | Q38289912 | ||
| Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice | Q38345765 | ||
| Bacterial CpG-DNA aggravates immune complex glomerulonephritis: role of TLR9-mediated expression of chemokines and chemokine receptors. | Q38358444 | ||
| Greater impact of dietary fat manipulation than apolipoprotein E genotype on ex vivo cytokine production - insights from the SATgenε study | Q38557941 | ||
| Sex differences in immune variables and respiratory infection incidence in an athletic population. | Q39766717 | ||
| Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation | Q40173384 | ||
| Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. | Q42021723 | ||
| Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens | Q42261747 | ||
| Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus. | Q43258243 | ||
| Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB x NZWF1 mice | Q44687455 | ||
| Treatment with anti-TGF-beta antibody ameliorates chronic progressive nephritis by inhibiting Smad/TGF-beta signaling | Q44692945 | ||
| Urinary transforming growth factor-beta 1 in various types of nephropathy | Q44730407 | ||
| Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice | Q46829591 | ||
| Toll-like receptor 9 signaling protects against murine lupus | Q46872996 | ||
| Levels of transforming growth factor-beta are low in systemic lupus erythematosus patients with active disease. | Q53170451 | ||
| Systemic lupus erythematosus | Q55933861 | ||
| Imatinib ameliorates renal disease and survival in murine lupus autoimmune disease | Q57702684 | ||
| Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192 | Q61646585 | ||
| PDGF and TGF-beta contribute to the natural course of human IgA glomerulonephritis | Q70847479 | ||
| Systemic lupus erythematosus | Q71046919 | ||
| Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease | Q71153700 | ||
| Gene expression of PDGF and PDGF receptor in various forms of glomerulonephritis | Q73126828 | ||
| Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells | Q77357447 | ||
| Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process | Q79318117 | ||
| Measurement of cytokine production using whole blood | Q81142261 | ||
| Expression of Toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis | Q83022836 | ||
| Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis | Q84080695 | ||
| Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation | Q86553655 | ||
| Effect of renal disease on the standardized mortality ratio and life expectancy of patients with systemic lupus erythematosus | Q86932194 | ||
| P433 | issue | 1 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| toll-like receptor | Q408004 | ||
| P304 | page(s) | 70 | |
| P577 | publication date | 2017-03-29 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | Excessive activation of the TLR9/TGF-β1/PDGF-B pathway in the peripheral blood of patients with systemic lupus erythematosus | |
| P478 | volume | 19 |
| Q55163735 | Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus. |
| Q91526078 | Cytokine signatures associate with disease severity in children with Mycoplasma pneumoniae pneumonia |
| Q42374957 | Interleukin 17A as a good predictor of the severity of Mycoplasma pneumoniae pneumonia in children |
| Q52726017 | Polymer-Mediated Inhibition of Pro-invasive Nucleic Acid DAMPs and Microvesicles Limits Pancreatic Cancer Metastasis. |
| Q52725381 | The non-haemostatic role of platelets in systemic lupus erythematosus. |
| Q55410580 | Transcriptome Analysis of Bronchoalveolar Lavage Fluid From Children With Mycoplasma pneumoniae Pneumonia Reveals Natural Killer and T Cell-Proliferation Responses. |
Search more.